News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Beijing Med-Pharm Corp. (BJGP.PK) Announces Exclusive Agreement to Market Enablex(R) in China


11/26/2007 11:14:57 AM

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Beijing Med-Pharm Corporation (NASDAQ:BJGP) (“Beijing Med-Pharm” or the “Company”), one of China’s leading pharmaceutical companies, and Shanghai Novartis Trading Limited, a wholly owned subsidiary of Novartis AG (NYSE: NVS), one of the top five pharmaceutical companies in the world, today announced an exclusive agreement to register, market and distribute Enablex® (Darifenacin) in the People's Republic of China.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES